Sequential steps in synaptic targeting of sensory afferents are mediated by constitutive and developmentally regulated glycosylations of CAMs.
Sensory afferents in the leech are labeled with both constitutive and developmentally regulated glycosylations (markers) of their cell adhesion molecules (CAMs). Their constitutive mannose marker, recognized by Lan3-2 monoclonal antibody (mAb), mediates the formation of their diffuse central arbors. We show that, at the ultrastructural level, these arbors consist of large, loosely organized axons rich with filopodia and synaptic vesicles. Perturbing the mannose-specific adhesion of this first targeting step leads to a gain in cell-cell contact but a loss of filopodia and synaptic vesicles. During the second targeting step, galactose markers divide afferents into different subsets. We focus on the subset labeled by the marker recognized by Laz2-369 mAb. Initially, the galactose marker appears where afferents contact central neurons. Subsequently it spreads proximally and distally, covering the entire afferent surface. Afferents now gain cell-cell contact, with central neurons and self-similar afferents, but lose filopodia and synaptic vesicles. Extant synaptic vesicles prevail where afferents are apposed to central neurons. These neurons develop postsynaptic densities and en passant synapses are forming. Perturbing the galactose-specific adhesion of this second targeting step causes a loss of cell-cell contact but a gain in filopodia and synaptic vesicles, essentially returning afferents to the first targeting step. The transformation of afferent growth, progressing from mannose- to galactose-specific adhesion, is consistent with a change from cell-matrix to cell-cell adhesion. By performing opposing functions in a temporal sequence, constitutive and developmentally regulated glycosylations of CAMs collaborate in the synaptogenesis of afferents and the consolidation of self-similar afferents.
Tai
M H
MH
Department of Physiology, Michigan State University, East Lansing, Michigan 48824, USA.
Zipser
B
B
D000367:Age Factors; D000818:Animals; D000911:Antibodies, Monoclonal; D015415:Biomarkers; D015815:Cell Adhesion Molecules / Q000502:physiology*; D002450:Cell Communication; D002490:Central Nervous System / Q000502:physiology / Q000648:ultrastructure; D005690:Galactose / Q000494:pharmacology / Q000502:physiology; D017952:Ganglia, Invertebrate / Q000187:drug effects / Q000502:physiology; D018507:Gene Expression Regulation, Developmental; D006031:Glycosylation; D007865:Leeches / Q000196:embryology* / Q000502:physiology* / Q000648:ultrastructure; D008358:Mannose / Q000494:pharmacology / Q000502:physiology; D008953:Models, Anatomic; D008954:Models, Biological; D009475:Neurons, Afferent / Q000648:ultrastructure; D011554:Pseudopodia / Q000187:drug effects; D013572:Synaptic Vesicles / Q000502:physiology* / Q000648:ultrastructure
D000911:Antibodies, Monoclonal; D015415:Biomarkers; D015815:Cell Adhesion Molecules; D008358:Mannose; D005690:Galactose